✦ LIBER ✦

Intravenous treatment of experimentalStaphylococcus aureusendophthalmitis: imipenem versus the combination of ceftazidime and amikacin

✍ Scribed by Michael Engelbert; Herminia Miño de Kaspar; Martina Mette; Martin Thiel; Christopher N. Ta; Thomas Grasbon; Markus Schulze-Schwering; Volker Klauss; Anselm Kampik

Publisher: Springer-Verlag
Year: 2003
Tongue: English
Weight: 423 KB
Volume: 241
Category: Article
ISSN: 0065-6100
DOI: 10.1007/s00417-003-0768-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravitreal vancomycin and amikacin ver

Intravitreal vancomycin and amikacin versus intravenous imipenem in the treatment of experimentalStaphylococcus aureusendophthalmitis

✍ Michael Engelbert; Herminia Miño de Kaspar; Martin Thiel; Thomas Grasbon; Christ 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 313 KB

In vitro activity of fosfomycin combined

In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin againstPseudomonas aeruginosa

✍ F. Tessier; C. Quentin 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 395 KB

Meropenem monotherapy versus combination

Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients

✍ G. Behre; H. Link; G. Maschmeyer; P. Meyer; U. Paaz; M. Wilhelm; W. Hiddemann 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 189 KB

In vitro activity of Aztreonam, Cefotaxi

In vitro activity of Aztreonam, Cefotaxime, Ceftazidime and Imipenem combined with Ciprofloxacin against Gram-negative bacilli and compared with amikacin combinations againstPseudomonas aeruginosa

✍ M. Díez Enciso 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 38 KB

In vitro activity of aztreonam, cefotaxi

In vitro activity of aztreonam, cefotaxime, ceftazidime and imipenem combined with ciprofloxacin against gram-negative bacilli and compared with amikacin combinations againstPseudomonas aeruginosa

✍ M. Díez Enciso 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 374 KB

Clinafloxacin monotherapy (CI-960) versu

Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patients

✍ M. P. Glauser; U. Brennscheidt; O. Cornely; A. Grigg; A. Figuera; C. Keyserling; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB